Tobacco News and Research

RSS

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

A recent study presented at the American College of Cardiology 64th Annual Scientific Meeting evaluated the impact of an age, sex, and gene expression score on clinical decision-making and the rate of further cardiac evaluation in symptomatic female patients suggestive of CAD in the outpatient setting.

17 Jun 2015

Only half of all Americans protected from secondhand smoke exposure

Many Americans view smoking, and secondhand smoke, as a problem that has mostly been solved, at least in the United States. However, only half of all Americans are protected from exposure to secondhand smoke, whether in public places or at work.

16 Jun 2015

Men's poor health costs $36.9 billion a year for Canada

Canadian Men's Health Week is kicking off with an urgent message: Unhealthy lifestyle choices are running rampant, and they are costing this country an arm and a leg.

15 Jun 2015

New study finds that children's exposure to second-hand smoke in England declines by 80%

A new study published today by the scientific journal Addiction finds that in England, children's exposure to second-hand smoke has declined by approximately 80% since 1998.

12 Jun 2015

Study highlights the need to reduce non-communicable diseases

There is a great need to slow down the increasing number of people who die prematurely because of non-communicable diseases (NCDs) such as cardiovascular disease, diabetes and cancer.

10 Jun 2015

Wistar Institute scientists find new biomarker that appears to be more accurate at detecting NSCLC

Survival rates for patients with lung cancer increase dramatically the earlier the disease is diagnosed, underscoring the need for effective biomarkers that can be used for detection. Now, scientists at The Wistar Institute have found a protein that circulates in the blood that appears to be more accurate at detecting non-small cell lung cancer (NSCLC) than currently available methods used for screening.

4 Jun 2015

EMA grants Orphan Drug Designation to Stempeucel for treatment of Thromboangiitis Obliterans

Stempeutics Research, a group company of Manipal Education & Medical Group and a joint venture with Cipla Group, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation for its drug Stempeucel® for the treatment of Thromboangiitis Obliterans.

2 Jun 2015

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Novartis today announced new data from two Phase II studies of Zykadia (ceritinib), as well as one Phase II study of Tafinlar® (dabrafenib) in combination with Mekinist (trametinib) in certain patients with non-small cell lung cancer.

2 Jun 2015

Phase 2 results from Abbvie’s veliparib study in NSCLC presented at ASCO 2015

AbbVie, a global biopharmaceutical company, today announced findings from a Phase 2 study of the investigational medicine veliparib combined with the chemotherapy regimen carboplatin and paclitaxel that showed an improvement in median progression-free survival (PFS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC) who are current smokers.

2 Jun 2015

New figures show that adults in East Midlands do not trust the tobacco industry

On World No Tobacco Day, new figures show that adults in the East Midlands don’t trust the tobacco industry. This is at a time when tobacco companies have been lobbying local and national governments to work with them more closely.

2 Jun 2015

Smoking cannabis may reduce chances of infection by intestinal worms

Washington State University researchers have found that the more hunter-gatherers smoke cannabis, the less they are infected by intestinal worms. The link suggests that they may unconsciously be, in effect, smoking medical marijuana.

1 Jun 2015

Combination of Mekinist and Tafinlar drugs improves outcome in patients with metastatic melanoma

Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.

1 Jun 2015

The Union calls on countries to join together to uphold tobacco packaging and labelling laws

On World No Tobacco Day 2015, The Union calls on countries to work together to introduce and uphold the tobacco packaging and labelling laws that have proven both to help tobacco users quit and discourage others from trying these highly addictive products.

30 May 2015

For World No-Tobacco Day WHO makes a stand against illicit tobacco trade

May 31 2015 is World No Tobacco Day and the World Health Organization (WHO) is using this opportunity to bring attention to the illicit trade in tobacco and try to bring an end to it by urging Member States to sign the Protocol to Eliminate the Illicit Trade in Tobacco Products...

29 May 2015

Practical guidance to ensure safe use of flavourings in e-cigarettes

The first practical guide to ensure the safe use of flavourings in e-cigarettes has been published. E-cigarettes and other vaping products contain a nicotine-based liquid that is vapourised and inhaled. There is no combustion so the user inhales vapour, not smoke. This means that e-cigarettes deliver nicotine without smoke toxicants. However, some in the public health community still have expressed concerns over the potential health impacts of flavourings used in e-cigarettes.

29 May 2015

MedUni Vienna expert suggests pricing strategy to reduce smoking

30% of the estimated 2.3 million smokers in Austria are considered to be heavily tobacco-dependent and, according to experts at MedUni Vienna, require professional treatment. This would mean around 690,000 people. According to Michael Kunze, an expert on smoking at the Center for Public Health at MedUni Vienna, an effective strategy would be to increase the price of tobacco products: "If the price of cigarettes were to rise just one percent above the inflation rate, that would bring about a 0.5% reduction in consumption worldwide."

29 May 2015

Tobacco News and Research

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

Only half of all Americans protected from secondhand smoke exposure

Men's poor health costs $36.9 billion a year for Canada

New study finds that children's exposure to second-hand smoke in England declines by 80%

Study highlights the need to reduce non-communicable diseases

Wistar Institute scientists find new biomarker that appears to be more accurate at detecting NSCLC

EMA grants Orphan Drug Designation to Stempeucel for treatment of Thromboangiitis Obliterans

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Phase 2 results from Abbvie’s veliparib study in NSCLC presented at ASCO 2015

New figures show that adults in East Midlands do not trust the tobacco industry

Smoking cannabis may reduce chances of infection by intestinal worms

Combination of Mekinist and Tafinlar drugs improves outcome in patients with metastatic melanoma

The Union calls on countries to join together to uphold tobacco packaging and labelling laws

For World No-Tobacco Day WHO makes a stand against illicit tobacco trade

Practical guidance to ensure safe use of flavourings in e-cigarettes

MedUni Vienna expert suggests pricing strategy to reduce smoking

Therapy for genetically-caused emphysema slows progression of lung disease

UM researcher receives grant to examine effects of CBT on racial/ethnic minority smokers

LSDF awards $2.9 million in funding to help commercialize major medical breakthroughs

Researchers use American College of Cardiology registry to improve cardiovascular care delivery in India

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News